Literature DB >> 1097135

Sex hormone levels and gonadotrophin release in the polycystic ovary syndrome.

N M Duignan, R W Shaw, B T Rudd, G Holder, J W Williams, W R Butt, R Logan-Edwards, D R London.   

Abstract

The response to synthetic luteinizing hormone-releasing hormone was studied in eighteen patients with the polycystic ovary syndrome. The release of follicle-stimulating hormone was similar to that found in normal women. The mean response of luteinizing hormone was similar to that found in the luteal phase, but significantly greater (P less than 0-02) than that found in the early follicular phase of the normal menstrual cycle. Basal serum levels of FSH and LH, estimated in twenty-five patients, were similar to those found in normal subjects. The sex hormone binding globulin capacity was reduced in twenty-four of them. Basal serum testosterone levels were elevated in twelve of twenty-two patients and the mean level was significantly greater (P less than 0-01) than the mean level of normal women. Basal serum androstenecione levels were elevated in nine of twenty-two patients and the mean level was also significantly greater (P leess than 0-001) between basal testosterone and LH levels. These data suggest the pituitary gland of patients with the polycystic ovary syndrome contains adequate amounts of LH but that the ovulatory surge of LH which occurs in normal women is inhibited by testosterone acting on either the pituitary or, more probably, on the hypothalamus.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1097135     DOI: 10.1111/j.1365-2265.1975.tb01536.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  4 in total

1.  Measurement of urine 17-oxogenic steroids, 17-hydroxycorticosteroids, and 17-oxosteroids has been superseded by better tests.

Authors:  B T Rudd
Journal:  Br Med J (Clin Res Ed)       Date:  1985-09-21

2.  The biochemical investigation of the infertile couple.

Authors:  R R O'Moore
Journal:  Ir J Med Sci       Date:  1979-02       Impact factor: 1.568

3.  Recurrent breast cancer treated with the antioestrogen tamoxifen: correlation between hormonal changes and clinical course.

Authors:  K J Willis; D R London; H W Ward; W R Butt; S S Lynch; B T Rudd
Journal:  Br Med J       Date:  1977-02-12

4.  Polycystic ovarian disease: endocrinological parameters with specific reference to growth hormone and somatomedin-C.

Authors:  W Urdl
Journal:  Arch Gynecol Obstet       Date:  1988       Impact factor: 2.344

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.